As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....